TickerFacts.

Company research / GEHC

GE HealthCare Technologies Inc. (GEHC)

Build a valuation ↗↓ Download CSV

CIK 0001932393 · Nasdaq · X-Ray Apparatus & Tubes & Related Irradiation Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, GE HealthCare Technologies Inc. reported revenue of $20.62B. Revenue grew 4.8% from the prior annual period. Over the twelve months to 2026-03-31, revenue was $20.98B.

Key ratios (year ended 2025-12-31)

40.0%
Gross margin
13.4%
Operating margin
10.1%
Net margin
20.1%
Return on year-end equity
4.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-22

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-03-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-03-31		2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue$20.98B$20.62B$19.67B$19.55B$18.34B$17.59B
Gross Profit$8.21B$8.25B$8.21B$7.92B$7.18B$7.17B
R&D Expense$1.26B$1.26B$1.31B$1.21B$1.03B$816.00M
Operating Income$2.65B$2.76B$2.62B$2.44B$2.52B$2.79B
Net Income$1.91B$2.08B$1.99B$1.57B$1.92B$2.25B
EPS (Diluted)n/a$4.55$4.34$3.03$4.22$4.95
Total Assets$37.12B$36.91B$33.09B$32.45B$27.54Bn/a
Total Liabilities$26.23B$26.31B$24.44B$25.14B$17.95Bn/a
Long-Term Debt$10.13B$10.00B$8.95B$9.44B$8.25Bn/a
Shareholders' Equity$10.68B$10.39B$8.46B$7.14B$9.36B$16.68B
Cash & Equivalents$2.26B$4.49B$2.87B$2.49B$1.44Bn/a
Operating Cash Flown/a$1.99B$1.96B$2.10B$2.13B$1.61B
Capital Expenditures$508.00M$482.00M$401.00M$387.00M$310.00M$248.00M
Free Cash Flown/a$1.50B$1.55B$1.71B$1.82B$1.36B
Share Repurchases$300.00M$200.00M$0$0n/an/a
Dividends Paid$64.00M$64.00M$55.00M$41.00M$0$0
Shares Outstandingn/an/an/a455.34Mn/an/a
Dividends Per Sharen/a$0.14$0.12$0.12n/an/a
Weighted Average Diluted Sharesn/a458.00M459.00M458.00M454.00M454.00M
EPS (Basic)n/a$4.56$4.37$3.05$4.22$4.95

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView